GRAND RAPIDS, Mich., May 4 (UPI) -- U.S. medical scientists say they've determined two types of kidney tumors previously thought to be different diseases are variations of the same one.
... humans but does not work in 75 percent of kidney tumor cells. Giaccia's team searched ... treatments.
"These results can be extended far beyond kidney cancer," Chan said.
The findings also speak well ...
... colleagues have also pioneered robotic surgery for smaller kidney tumors, allowing them to perform a partial ... moves the large intestine aside to reach the kidney; clips or ties off the vein and artery ...
... function when devising treatment plans for patients with kidney tumors," said Pettus.
He said the findings raise ... 7 cm or less, partial removal of the kidney provides equal cancer control to total ...
... cryoablation is the first-line treatment for small tumors. Most of our patients go home the same day ... benchmark within the medical community to gauge the success of a kidney tumor treatment option—since ...
... suppression."
The team looked at both mouse models and human tissue samples from liver, lung and kidney tumors. White indicates there is evidence that controlling p62 levels also ...
... injecting man-made, microscopic tubes into tumors and heating them with a quick, 30-second ... die.
Using a mouse model, researchers injected kidney tumors with different quantities of MWCNTs and exposed ...
... patient who underwent a partial nephrectomy, a procedure that removes a kidney tumor while leaving the non-cancerous part of the kidney intact, over a period of 3 hours and 30 minutes. ...
... was a 65 year-old female with a 6 cm left kidney tumor and a prior history of hysterectomy. The operation lasted 220 minutes followed by a two day hospital stay. The patient ...
... high-volume academic centers, where surgeons are experienced not only in resection of very complex kidney tumors but also in minimally-invasive techniques to treat patients with kidney cancer.
There ...
... investigators working in collaboration with Cleveland Clinic researchers have determined that two types of kidney tumors previously thought to be different diseases are actually variations of the same ...
... numerous tumor sites, including breast prostate, lung, pancreas, ovarian, colon, kidney tumors, and angiosarcomas. The scientists found that SFRP2 is a potent stimulator of angiogenesis. This protein ...
... little about the function of the protein except that it is mutated in some rare hereditary and sporadic kidney tumors. That result suggests that one of the normal targets of TRC8 helps spur cancer.
